Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.57 |
| ▸ | CHEK1 | O14757 | 18/20 | 0.55 |
| ▸ | CCNA2 | P20248 | 12/20 | 0.55 |
| ▸ | CDK2 | P24941 | 12/20 | 0.55 |
| ▸ | CCNA1 | P78396 | 12/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12952898 | 0.89 | GSK3B (0.72) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL13305375 | 0.89 | GSK3B (0.57) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL13304821 | 0.88 | GSK3B (0.53) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL13146283 | 0.84 | GSK3B (0.81) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL13305036 | 0.78 | GSK3B (0.55) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL12953804 | 0.77 | GSK3B (0.69) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL13304793 | 0.74 | MAPK1 (0.41) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL13305295 | 0.73 | GSK3B (0.81) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL12953000 | 0.73 | GSK3B (1.00) | GSK3BCHEK1CCNA2CDK2CCNA1 | |
| SCHEMBL13304869 | 0.72 | GSK3B (0.77) | GSK3BCHEK1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537116-B1 | PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |